MedPath

Betamethasone LA effects versus Dexamethasone in treatment of Sudden Sensory Hearing Loss

Phase 3
Recruiting
Conditions
sudden sensorineural hearing loss.
Sudden idiopathic hearing loss
Registration Number
IRCT2017012832069N2
Lead Sponsor
Vice chancellor for research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
94
Inclusion Criteria

age between 18-70 years old; patient with SSHL
and history of systemic corticosteroids treatment without response to it; whitout history of ear disease; SSHL without certain causes.
Exclusion criteria: pathology in the middle ear (tympanic membrane perforation, surgery on the ear) bilateral SSHL; previous intratympanic injection for the same disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hearing cutoff. Timepoint: Before intervation, after intervation at force,1month after intervation,2months after the end of the intervation,6months after the end of the intervation. Method of measurement: PTA.
Secondary Outcome Measures
NameTimeMethod
Vertigo. Timepoint: After the end of the intervation at force,1month and 2months and 6months after the end of the intervation. Method of measurement: Questionary.
© Copyright 2025. All Rights Reserved by MedPath